DekaBank Deutsche Girozentrale’s Immunovant IMVT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$794K	Hold	32,600	–	–	﹤0.01%	821
2026 Q1	$811K	Hold	32,600	–	–	﹤0.01%	822
2025 Q4	$1.15M	Hold	32,600	–	–	﹤0.01%	848
2025 Q3	$1.14M	Hold	32,600	–	–	﹤0.01%	849
2025 Q2	$1.15M	Hold	32,600	–	–	﹤0.01%	836
2025 Q1	$1.06M	Hold	32,600	–	–	﹤0.01%	837
2024 Q4	$1M	Hold	32,600	–	–	﹤0.01%	874
2024 Q3	$1.06M	Hold	32,600	–	–	﹤0.01%	874
2024 Q2	$1.06M	Hold	32,600	–	–	﹤0.01%	866
2024 Q1	$1.06M	Hold	32,600	–	–	﹤0.01%	864
2023 Q4	$1.38M	Hold	32,600	–	–	﹤0.01%	847
2023 Q3	$1.3M	Hold	32,600	–	–	﹤0.01%	831
2023 Q2	$604K	Hold	32,600	–	–	﹤0.01%	991
2023 Q1	$504K	Hold	32,600	–	–	﹤0.01%	1007
2022 Q4	$568K	Hold	32,600	–	–	﹤0.01%	1007
2022 Q3	$177K	Hold	32,600	–	–	﹤0.01%	1246
2022 Q2	$132K	Hold	32,600	–	–	﹤0.01%	1256
2022 Q1	$179K	Buy	32,600 +3,000	+10%	+$18.7K	﹤0.01%	1228
2021 Q4	$231K	Buy	29,600 +1,000	+3%	+$8.26K	﹤0.01%	1250
2021 Q3	$252K	Hold	28,600	–	–	﹤0.01%	1164
2021 Q2	$309K	Hold	28,600	–	–	﹤0.01%	1140
2021 Q1	$429K	Hold	28,600	–	–	﹤0.01%	1056
2020 Q4	$1.38M	Buy	+28,600	New	+$1.32M	0.01%	766

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DekaBank Deutsche Girozentrale's IMVT Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Immunovant (IMVT) position steady in Q2 2026 at 32,600 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #821.

DekaBank Deutsche Girozentrale first reported a position in IMVT in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.38M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

DekaBank Deutsche Girozentrale held 32,600 shares of Immunovant worth $794K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Immunovant share count unchanged in Q2 2026.
Immunovant made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #821 holding.
DekaBank Deutsche Girozentrale first reported a position in Immunovant in Q4 2020 and has held it in 23 quarters since.
DekaBank Deutsche Girozentrale's Immunovant position peaked at $1.38M in Q4 2023.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.